Europe Uveitis Market and Competitive Landscape – 2017
The latest research from Fore Pharma, Europe Uveitis Market and Competitive Landscape – 2017, provides comprehensive insights into Uveitis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Uveitis market size and drug sales. This research also provides insights into Uveitis epidemiology and late stage pipeline.
The report is classified into nine sections – Uveitis overview with definitions, symptoms, etiology, diagnosis, treatment options; Uveitis pipeline insights covering late stage clinical trials pipeline; Uveitis prevalence trends by countries; Uveitis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.
Research Scope:
- Uveitis pipeline: Find out the drugs in clinical trials for Uveitis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Uveitis epidemiology: Find out the prevalence of Uveitis by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Uveitis products: Identify key products marketed and prescribed for Uveitis by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
- Uveitis market size: Find out the market size for Uveitis drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Uveitis drug sales: Find out the sales of Uveitis drugs by countries – Europe, Germany, France, Italy, Spain, UK
- Uveitis drugs sales forecast: Sales forecast for Uveitis drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
- Uveitis market share analysis: Find out the market shares of Uveitis drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
- Evaluate commercial market opportunities for Uveitis drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in Uveitis market
- Develop in-depth knowledge of competition and markets
- Analyze sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track market trends and analyze key events in Uveitis market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
- 1. Uveitis: Disease Overview
- 1.1. Uveitis Symptoms
- 1.2. Uveitis Etiology
- 1.3. Uveitis Diagnosis
- 1.4. Uveitis Treatment Options
- 2. Uveitis Pipeline Insights
- 2.1. Uveitis Phase 3 Clinical Trials
- 2.2. Uveitis Phase 2 Clinical Trials
- 2.3. Uveitis Phase 1 Clinical Trials
- 3. Uveitis Epidemiology Analysis
- 4. Germany Uveitis Market Insights
- 4.1. Marketed Products for Uveitis in Germany
- 4.2. Germany Uveitis Market Size & Forecast
- 4.3. Germany Uveitis Product Sales Forecast
- 4.4. Germany Uveitis Market Share Analysis
- 5. France Uveitis Market Insights
- 5.1. Marketed Products for Uveitis in France
- 5.2. France Uveitis Market Size & Forecast
- 5.3. France Uveitis Product Sales Forecast
- 5.4. France Uveitis Market Share Analysis
- 6. Italy Uveitis Market Insights
- 6.1. Marketed Products for Uveitis in Italy
- 6.2. Italy Uveitis Market Size & Forecast
- 6.3. Italy Uveitis Product Sales Forecast
- 6.4. Italy Uveitis Market Share Analysis
- 7. Spain Uveitis Market Insights
- 7.1. Marketed Products for Uveitis in Spain
- 7.2. Spain Uveitis Market Size & Forecast
- 7.3. Spain Uveitis Product Sales Forecast
- 7.4. Spain Uveitis Market Share Analysis
- 8. UK Uveitis Market Insights
- 8.1. Marketed Products for Uveitis in UK
- 8.2. UK Uveitis Market Size & Forecast
- 8.3. UK Uveitis Product Sales Forecast
- 8.4. UK Uveitis Market Share Analysis
- 9. Europe Uveitis Market Insights
- 9.1. Europe Uveitis Market Size & Forecast
- 9.2. Europe Uveitis Product Sales Forecast
- 9.3. Europe Uveitis Market Share Analysis
- 10. Research Methodology
- LIST OF TABLES
- Table 1: Uveitis Phase 3 Clinical Trials, Global, 2017
- Table 2: Uveitis Phase 2 Clinical Trials, Global, 2017
- Table 3: Uveitis Phase 1 Clinical Trials, Global, 2017
- Table 4: Uveitis Prevalence by EU5 Countries, 2012 - 2021
- Table 5: Marketed Products for Uveitis in Germany, 2017
- Table 6: Germany Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 7: Germany Uveitis Product Sales ($mn), 2012 - 2021
- Table 8: Germany Uveitis Market Trends, 2012 - 2021
- Table 9: Marketed Products for Uveitis in France, 2017
- Table 10: France Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 11: France Uveitis Product Sales ($mn), 2012 - 2021
- Table 12: France Uveitis Market Trends, 2012 - 2021
- Table 13: Marketed Products for Uveitis in Italy, 2017
- Table 14: Italy Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 15: Italy Uveitis Product Sales ($mn), 2012 - 2021
- Table 16: Italy Uveitis Market Trends, 2012 - 2021
- Table 17: Marketed Products for Uveitis in Spain, 2017
- Table 18: Spain Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 19: Spain Uveitis Product Sales ($mn), 2012 - 2021
- Table 20: Spain Uveitis Market Trends, 2012 - 2021
- Table 21: Marketed Products for Uveitis in UK, 2017
- Table 22: UK Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 23: UK Uveitis Product Sales ($mn), 2012 - 2021
- Table 24: UK Uveitis Market Trends, 2012 - 2021
- Table 25: Europe Uveitis Market Size & Forecast ($mn), 2012 - 2021
- Table 26: Europe Uveitis Product Sales ($mn), 2012 - 2021
- LIST OF FIGURES
- Figure 1: Uveitis Pipeline by Phase (%), Global, 2017
- Figure 2: Uveitis Prevalence by EU5 Countries, 2012 - 2021
- Figure 3: Germany Uveitis Market Size ($mn), 2012 - 2021
- Figure 4: Germany Uveitis Product Sales ($mn), 2012 - 2021
- Figure 5: Germany Uveitis Market Share by Products (%), 2016
- Figure 6: Germany Uveitis Market - Future Market Share (%), 2021
- Figure 7: France Uveitis Market Size ($mn), 2012 - 2021
- Figure 8: France Uveitis Product Sales ($mn), 2012 - 2021
- Figure 9: France Uveitis Market Share by Products (%), 2016
- Figure 10: France Uveitis Market - Future Market Share (%), 2021
- Figure 11: Italy Uveitis Market Size ($mn), 2012 - 2021
- Figure 12: Italy Uveitis Product Sales ($mn), 2012 - 2021
- Figure 13: Italy Uveitis Market Share by Products (%), 2016
- Figure 14: Italy Uveitis Market - Future Market Share (%), 2021
- Figure 15: Spain Uveitis Market Size ($mn), 2012 - 2021
- Figure 16: Spain Uveitis Product Sales ($mn), 2012 - 2021
- Figure 17: Spain Uveitis Market Share by Products (%), 2016
- Figure 18: Spain Uveitis Market - Future Market Share (%), 2021
- Figure 19: UK Uveitis Market Size ($mn), 2012 - 2021
- Figure 20: UK Uveitis Product Sales ($mn), 2012 - 2021
- Figure 21: UK Uveitis Market Share by Products (%), 2016
- Figure 22: UK Uveitis Market - Future Market Share (%), 2021
- Figure 23: Europe Uveitis Market Size ($mn), 2012 - 2021
- Figure 24: Europe Uveitis Product Sales ($mn), 2012 - 2021
- Figure 25: Europe Uveitis Market Share by Products (%), 2016
- Figure 26: Europe Uveitis Market - Future Market Share (%), 2021